ibrutinib — integMET

Metabolite details

Identifier: XYFPWWZEPKGCCK-GOSISDBHSA-N
InChI Key: XYFPWWZEPKGCCK-GOSISDBHSA-N
IUPAC name: 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one
Preferred name: ibrutinib
INN name: ibrutinib
Synonym: PCI-32765
ChEBI: CHEBI:76612

R-HSA-1266695 - Interleukin-7 signaling
R-HSA-1280215 - Cytokine Signaling in Immune system
R-HSA-1280218 - Adaptive Immune System
R-HSA-1643685 - Disease
R-HSA-168256 - Immune System
R-HSA-449147 - Signaling by Interleukins
R-HSA-451927 - Interleukin-2 family signaling
R-HSA-5663205 - Infectious disease
R-HSA-6785807 - Interleukin-4 and Interleukin-13 signaling
R-HSA-8985947 - Interleukin-9 signaling
R-HSA-9020558 - Interleukin-2 signaling
R-HSA-9679191 - Potential therapeutics for SARS
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9824446 - Viral Infection Pathways
R-HSA-983695 - Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
R-HSA-983705 - Signaling by the B Cell Receptor (BCR)